HIV-infected individuals

Ranga U, Woffendin C, Verma S, Xu L, June CH, Bishop DK, Nabel GJ (1998) Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals, Proc Natl Acad Sci USA 95 1201-1206... 

Overall, it appears that immune reconstitution is only rarely associated with peripheral neuropathies in HIV-infected individuals. 

In parts of the world (sub-Sahran African and southern and South-East Asia) the ADDS pandemic is out of control, with no effective chemotherapeutic agents and little prospect of a vaccine the prognoses are bleak for the millions of HIV-infected individuals. Sexual intercourse is now the main mode of infection and if the pandemic is to be contained, sexually active individuals have to be persuaded to reduce the niunbers of their sex partners and to practise safe sex using condoms. 

Two major panels of experts publish guidelines for the treatment of HIV-infected individuals. Although the recommendations are quite similar, slight differences do exist between the Department of Health and Human Services (DHHS) Guidelines2 and the International AIDS Society-USA (IAS-USA) Panel Recommendations.4 The DHHS Guidelines are updated every 6 months and current and archived versions are available online at www.aidsinfo.nih.gov. The IAS-USA Guidelines were last updated in 2006, and in 2004 prior to that revision. Due to the intense research and constant modifications to therapeutic approaches in the treatment of HIV, the majority of the treatment algorithms and recommendations presented herein follow the most up-to-date information found in the DHHS recommendations. 

Kinter AL, Umscheid CA, Arthos J, et al. HIV envelope induces virus expression from resting CD4+ T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis. J Immunol 2003 170(5) 2449-2455. 

Oishi K, Hayano M, Yoshimine H, et al. Expression of chemokine receptors on CD4+ T cells in peripheral blood from HIV-infected individuals in Uganda. J Interferon Cytokine Res 2000 20(6) 597-602. 

Lima AAM, Silva TJ, Gifoni AMR, Barrett LJ, McAuliffe IT, Bao Y, Fox JW, Fedorko DP, Guerrant RL Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in Northeast Brazil. Am J Gastroenterol 1997 92 1861-1866. 

Regular, periodic measurement of plasma HIV RNA levels and CD4 cell counts is necessary to determine the risk of disease progression in an HIV-infected individual and to determine when to initiate or modify antiretroviral treatment regimens. 

The spectrum of infectious diseases observed in HIV-infected individuals and recommended first-line therapies are shown in Table 40-6. 

Therapies for Common Opportunistic Pathogens in HIV-Infected Individuals... 

Currently, PCP prophylaxis is recommended for all HIV-infected individuals who have already had previous PCP. Prophylaxis is also recommended for all HIV-infected persons who have a CD4 lymphocyte count of less than 200 cells/mm3 (i.e., their CD4 cells are less than 20% of total lymphocytes) or a history of oropharyngeal candidiasis. 

Human immunodeficiency virus (HIV) is the most important risk factor for active TB, especially among people 25 to 44 years of age. An HIV-infected individual with TB infection is over 100-fold more likely to develop active disease than an HIV-seronegative patient. 

B. cants is the species of Brucella species that can infect dogs, This species has occasionally been transmitted to humans, but the vast majority of dog infections do not result in human illness. Although veterinarians exposed to blood of infected animals are at risk, pet owners are not considered to be at risk for infection. This is partly because it is uniikely that they will come in contact with blood, semen, or placenta of the dog. The bacteria may be cleared from the animal within a few days of treatment however re infection is common and some animal body fluids may be infectious for weeks. Immunocompromised persons (cancer patients, HIV-infected individuals, or transplantation patients) should not handle dogs known to be infected with B. cams. 

The extent of HIV infection in sub-Saharan Africa is alarmingly high. For example, as many as 90% of female prostitutes in Kenya are infected with HIV, while as many as 25% of the sexually active population of several cities in Rwanda may be infected. There may be 10 million HIV-infected individuals in Africa many of them will probably progress to AIDS and eventually die. Another virus related to HIV has also been discovered in Africa. The original HIV, which is associated with the great majority of AIDS cases, is called HIV-1. The new virus is called HIV-2 and is predominantly found in countries along the West... 

It is important to note that these figures represent HIV-infected individuals detected by antibody test, and not AIDS cases. Since most of these individuals acquired the virus relatively recently, most have not yet begun to show signs of illness. However, we can predict that within a few years the number of AIDS cases in these countries will soar. 

Most HIV-infected individuals will develop some of the symptoms associated with AIDS within 8 to 10 years after initial infection. The rate at which infected... 

More sensitive tests for HIV are under development. This is important because in an HIV-infected individual, most cells are not infected, even among CD4-positive T lymphocytes and monocytes/macrophages. Newly developed techniques are dependent on molecular genetics (Dl). 

AZT works by specifically blocking DNA synthesis carried out by HIV reverse transcriptase. Other related compounds are also being tested to see if they specifically affect HIV reverse transcriptase. Such compounds might have equivalent antiviral effects. If they have fewer side effects than AZT, they may be even more effective in treating HIV-infected individuals. Two additional antivirals related to AZT have recently been approved for anti-HIV therapy, dideoxy-inosine (DDI) and dideoxycytosine (DDC). These drugs are predominantly recommended for individuals who cannot tolerate AZT, or for whom AZT has ceased to be effective although they are effective against HIV, they do have side effects. Nevertheless, they may be important because AZT does not indefinitely reduce the amount of virus in HIV-infected individuals. 

To get a sense of perspective, we have to look into time scales for some epidemics, including AIDS. First, the current estimates are that most HIV-infected individuals will develop AIDS with an average time between initial infection and disease symptoms of 8-10 years. Thus, new therapies and treatments that are developed in the next 10 years may be able to help many of those who are currently infected. 

Genital herpes Treatment or suppression of genital herpes in immunocompetent individuals and for the suppression of recurrent genital herpes in HIV-infected individuals. 

Non-HIV Infected individuals There is a theoretical risk that enfuvirtide use may lead to the production of antienfuvirtide antibodies that cross react with HIV gp41. This could result in a false positive HIV test with an ELISA assay a confirmatory western P.1126... 

Johns K, Beddall MJ, Corrin RC. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. Cochrane Database Syst Rev 2005. 

The immune reconstitution inflammatory syndrome (IRIS) has emerged as an important clinical issue in the management of HIV-infected individuals on ART. IRIS is characterized by paradoxical worsening of symptoms and signs of inflammation in individual on ART (usually 2-6 months after ART initiation) related to the immunological gains of ART. 

---